Press releases

Publication on Blood Cancer Discovery Further Validates Exscientia AI-powered Medicine Platform for Improving Patient Outcomes

The results support the screening deep learning drug ex vivo with patient tissue as a promising tool for finding effective and individual treatments for advanced blood cancer compared to conventional methods

Algorithms of deep learning customized and single cell analyzes of >1 billion patient cells reveal further potential to improve patient outcomes

Exscientia, ETH Zurich, the Medical University of Vienna, and the Center for Molecular Medicine (CeMM) today announced a new publication on Blood Cancer Discovery, the journal of the American Association for Cancer Research, entitled "Deep Morphology Learning Enhances Precision Medicine by Image-Based Ex Vivo Drug Testing”From the laboratory of Prof. Berend Snijder.

Innovation newsletter
Don't miss the most important news on innovation. Sign up to receive them by email.
Innovation newsletter
Don't miss the most important news on innovation. Sign up to receive them by email.

Latest Articles

Publishers and OpenAI sign agreements to regulate the flow of information processed by Artificial Intelligence

Last Monday, the Financial Times announced a deal with OpenAI. FT licenses its world-class journalism…

April 30 2024

Online Payments: Here's How Streaming Services Make You Pay Forever

Millions of people pay for streaming services, paying monthly subscription fees. It is common opinion that you…

April 29 2024

Veeam features the most comprehensive support for ransomware, from protection to response and recovery

Coveware by Veeam will continue to provide cyber extortion incident response services. Coveware will offer forensics and remediation capabilities…

April 23 2024

Green and Digital Revolution: How Predictive Maintenance is Transforming the Oil & Gas Industry

Predictive maintenance is revolutionizing the oil & gas sector, with an innovative and proactive approach to plant management.…

April 22 2024